Description

4-(4-Fluorobenzyl)-3-Oxo-3,4-Dihydropyrazine-2-Carboxylic Acid (Wxc01551) is a high-purity, advanced pharmaceutical intermediate characterized by its distinct pyrazine carboxylic acid structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in drug discovery programs.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop new chemical entities.
• API Synthesis: Serves as a precursor in the multi-step synthesis of potential Active Pharmaceutical Ingredients (APIs).
• Biochemical Research: Employed as a substrate or inhibitor in enzymatic studies due to its specific molecular framework.
• Fine Chemical Production: Integrated into the manufacturing of specialty and custom fine chemicals for advanced applications.

Basic Information

Product Name	4-(4-Fluorobenzyl)-3-Oxo-3,4-Dihydropyrazine-2-Carboxylic Acid (Wxc01551)
CAS No.	1956306-66-3
Molecular Formula	C12H9FN2O3
Molecular Weight	248.21 g/mol
Synonyms	4-[(4-Fluorophenyl)methyl]-3-oxo-3,4-dihydro-2-pyrazinecarboxylic acid; 2-Pyrazinecarboxylic acid, 3,4-dihydro-4-[(4-fluorophenyl)methyl]-3-oxo-; WXC01551; 4-(4-Fluorobenzyl)-3-oxo-3,4-dihydro-2-pyrazinecarboxylic acid; 4-(p-Fluorobenzyl)-3-oxo-3,4-dihydropyrazine-2-carboxylic acid
EINECS	Contact for details

Quality Control

Our 4-(4-Fluorobenzyl)-3-Oxo-3,4-Dihydropyrazine-2-Carboxylic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our commitment to quality supports compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, open flames, and incompatible materials. The container must be kept tightly sealed to protect the contents from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.